• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Surmodics Inc (NQ: SRDX )

    38.17 -0.39 (-1.01%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 180,762
    Open 38.58
    Bid (Size) 37.41 (1)
    Ask (Size) 41.99 (2)
    Prev. Close 38.56
    Today's Range 38.13 - 38.58
    52wk Range 25.17 - 42.44
    Shares Outstanding 14,134,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
    From Surmodics, Inc.
    Via Business Wire
    Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System
    From Surmodics, Inc.
    Via Business Wire

    Performance

    YTD
    +7.34%
    +7.34%
    1 Month
    -0.39%
    -0.39%
    3 Month
    -2.90%
    -2.90%
    6 Month
    +13.74%
    +13.74%
    1 Year
    +10.19%
    +10.19%

    More News

    Read More
    Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter
    From Surmodics, Inc.
    Via Business Wire
    SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024
    Via InvestorPlace
    Assessing Surmodics: Insights From 5 Financial Analysts
    Via Benzinga
    Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results
    From Surmodics, Inc.
    Via Business Wire
    SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, SRDX, AGS, VAPO on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
    From Surmodics, Inc.
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
    Via Investor's Business Daily
    Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
    Via Benzinga
    Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
    From Surmodics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
    From Surmodics, Inc.
    Via Business Wire
    Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
    From Surmodics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.